Advanced Search

 

Study ID Status Title Patient Level Data
116317 Completed Sentinel surveillance for influenza requiring hospital admission in Canadian adults
116318 Completed Plan for Re-Evaluation of Sudden Unexplained Death in Epilepsy (SUDEP) Occurring in the Lamotrigine Clinical Development Program
116343 Completed A Three Part, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of Inhaled and Intravenous GSK2862277 in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
116357 Completed Burden of respiratory syncytial virus (RSV) in the United Kingdom, 1995 to 2009
116364 Completed Study FFR116364, a double-blind, placebo-controlled study of GW685698X in paediatric subjects with perennial allergic rhinitis Study Listed on ClinicalStudyDataRequest.com
116365 Completed Study FFR116365, an open-label study of GW685698X in paediatric subjects with perennial allergic rhinitis Study Listed on ClinicalStudyDataRequest.com
116371 Completed A Phase 1, Open-Label, Crossover Study to Demonstrate the Bioequivalence of RYTHMOL SR® (propafenone hydrochloride) Manufactured at Two Different Sites Study Listed on ClinicalStudyDataRequest.com
116378 Completed A Single Blind (Sponsor-unblinded), Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of GSK1070806 in the Treatment of Obese Subjects with T2DM. Study Listed on ClinicalStudyDataRequest.com
116392 Completed A randomized, double blind, placebo-controlled study to investigate the safety and pharmacodynamics of repeat intranasal administration of the TLR7 agonist GSK2245035 in subjects with respiratory allergies Study Listed on ClinicalStudyDataRequest.com
116402 Completed A multi-national, randomized, double-blind, placebo-controlled, 3-period crossover study with GSK 573719 as monotherapy in adult subjects with asthma Study Listed on ClinicalStudyDataRequest.com
116415 Completed A randomized, double-blind, single dose, four way cross-over study to assess the systemic exposure, systemic pharmacodynamics and safety and tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol following single inhaled doses of Umeclidinium/Vilanterol blend + Fluticasone Furoate, Umeclidinium + Vilanterol, Fluticasone Furoate + Vilanterol and Fluticasone Furoate + Umeclidinium in healthy subjects Study Listed on ClinicalStudyDataRequest.com
116416 Completed Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects Study Listed on ClinicalStudyDataRequest.com
116441 Completed Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension. - A Single Oral Dose Study to Investigate Pharmacokinetics of Atovaquone and Proguanil from Combination Tablets and Atovaquone from Atovaquone Suspension in Japanese Healthy Males. -
116454 Active, Not Recruiting Special Drug Use Investigation for ReQuip® Controlled-Release (CR)
116455 Completed A Multi-Center, Open-labelled Study to Evaluate the Safety of Levocetirizine Hydrochloride Oral Solution in Children Aged 6 Months to 2 Years with Allergic Rhinitis or Pruritus Associated with the Skin Diseases.
116456 Recruiting A Post-Marketing Surveillance Study of Requip PD™ (Ropinirole) in the Treatment of Adult Filipino Patients diagnosed with Parkinson’s Disease
116459 Completed Pharmacokinetic Study of Levocetirizine Oral Solution-An open-label, randomized, cross-over study to evaluate the pharmacokinetics, the safety and tolerability of levocetirizine oral solution (5 mg) and cetirizine dry syrup (10 mg), following a single dose in Japanese healthy male subjects-
116477 Completed Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis Study Listed on ClinicalStudyDataRequest.com
116480 Completed An open label, balanced, randomized, three-treatment, three-period, six-sequence, cross-over, single dose, comparative bioavailability pilot study of two test formulations of fixed dose combination capsules of acetylsalicylic acid (ASA) and pantoprazole (Each capsule contains ASA 100 mg and pantoprazole 20 mg) manufactured by Piramal Healthcare Limited, India for GSK comparing with Aspirin® Protect 100 mg tablets by Bayer vital GmbH, and Protium® 20 mg gastro-resistant tablets by Nycomed GmbH, in healthy, adult, human subjects, under fasting conditions
116488 Active, Not Recruiting Drug Use Investigation for PAXIL Controlled-Release (CR)
116498 Completed An open label, balanced, randomized, three-treatment, three-period, six-sequence, cross-over, single dose, comparative bioavailability pilot study of two test formulations of fixed dose combination capsules of acetylsalicylic acid (ASA) and pantoprazole (Each capsule contains ASA 100 mg and pantoprazole 20 mg) manufactured by Piramal Healthcare Limited, India for GSK comparing with Aspirin® Protect 100 mg tablets by Bayer vital GmbH, and Protium® 20 mg gastro-resistant tablets by Nycomed GmbH, in healthy, adult, human subjects, under fed conditions
116511 Completed A single blind, randomized, placebo-controlled, dose escalating study to evaluate the safety, tolerability,pharmacokinetic and pharmacodynamic parameters of repeat doses of GSK2330672 in healthy volunteers, given alone and with a single day of dosing with GSK1614235 Study Listed on ClinicalStudyDataRequest.com
116513 Active, Not Recruiting A phase III, randomised, open-label study comparing the combination of the BRAF inhibitor, dabrafenib and the MEK inhibitor, trametinib to the BRAF inhibitor vemurafenib in subjects with unresectable (stage IIIc) or metastatic (stage IV) BRAF V600E/K mutation positive cutaneous melanoma
116519 Completed The effect of food on the pharmacokinetics of metformin given either as metformin hydrochloride SR 1000mg tablet or as a fixed dose combination of metformin hydrochloride SR 1000mg/glimepiride 2mg tablet in healthy Indian volunteers.
116524 Completed A randomized, double blind, single-dose, three-period, crossover study to investigate pharmacokinetic, safety and tolerability of Fluticasone Furoate with Umeclidinium when administered in combination and as monotherapies in adult healthy volunteer subjects Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.